AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 213 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,734,000 | -41.2% | 49,530 | -10.2% | 0.01% | -43.5% |
| Q2 2020 | $2,949,000 | +70.2% | 55,140 | +12.9% | 0.02% | +35.3% |
| Q1 2020 | $1,733,000 | -37.9% | 48,832 | -16.4% | 0.02% | -19.0% |
| Q4 2019 | $2,789,000 | +63.0% | 58,412 | +10.6% | 0.02% | +50.0% |
| Q3 2019 | $1,711,000 | -27.7% | 52,802 | +11.2% | 0.01% | -26.3% |
| Q2 2019 | $2,368,000 | -26.4% | 47,480 | -0.5% | 0.02% | -26.9% |
| Q1 2019 | $3,219,000 | +43.4% | 47,730 | -2.0% | 0.03% | +36.8% |
| Q4 2018 | $2,245,000 | -43.6% | 48,698 | -5.6% | 0.02% | -26.9% |
| Q3 2018 | $3,978,000 | +2.4% | 51,579 | +11.9% | 0.03% | 0.0% |
| Q2 2018 | $3,884,000 | -3.1% | 46,109 | -5.9% | 0.03% | +160.0% |
| Q1 2018 | $4,009,000 | +37.3% | 49,024 | -4.0% | 0.01% | +42.9% |
| Q4 2017 | $2,920,000 | -29.1% | 51,064 | -17.2% | 0.01% | -30.0% |
| Q3 2017 | $4,117,000 | +28.1% | 61,676 | -1.3% | 0.01% | +11.1% |
| Q2 2017 | $3,214,000 | -0.3% | 62,462 | +13.2% | 0.01% | 0.0% |
| Q1 2017 | $3,223,000 | +53.6% | 55,192 | +9.8% | 0.01% | +50.0% |
| Q4 2016 | $2,098,000 | -50.1% | 50,272 | -36.9% | 0.01% | -53.8% |
| Q3 2016 | $4,208,000 | +54.4% | 79,656 | +22.5% | 0.01% | +44.4% |
| Q2 2016 | $2,725,000 | -2.9% | 65,039 | -5.9% | 0.01% | 0.0% |
| Q1 2016 | $2,806,000 | -52.7% | 69,114 | -24.3% | 0.01% | -47.1% |
| Q4 2015 | $5,927,000 | -19.7% | 91,300 | -12.6% | 0.02% | -26.1% |
| Q3 2015 | $7,377,000 | -38.5% | 104,505 | -3.2% | 0.02% | -23.3% |
| Q2 2015 | $12,000,000 | +37.5% | 107,968 | +16.6% | 0.03% | +42.9% |
| Q1 2015 | $8,729,000 | +8.7% | 92,569 | +29.2% | 0.02% | +5.0% |
| Q4 2014 | $8,027,000 | +76.8% | 71,647 | -3.2% | 0.02% | +81.8% |
| Q3 2014 | $4,540,000 | +35.2% | 74,002 | +1.0% | 0.01% | +37.5% |
| Q2 2014 | $3,357,000 | – | 73,275 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |